west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "Topiramate/Topamax" 1 results
  • Clinical Evidences for Topiramate in Intractable Epilepsy Treating

    We searched The Cochrane Library(Issue 3, 2005), MEDLINE(1996-2005) ,CMCC(1996-2005), VIP(1996-2005) ,CNKI(1996-2005) to summarize the available evidence of topiramate for an intractable epilepsy. After scanning all these articles, we identified 11 articles including meta-analysis, randomised controlled trials and systematic reviews to evaluate. Topiramate offered an alternative in the treament for intractable epilepsy, especially for partial epilepsy, and its efficacy was proven. Patients had good tolerance. And no intercross effects with the traditional anti-epileptic drugs were found. So topiramate had broad clinical value. The primary dosage of topiramate was 200mg/d. The sustaining dosage was 400-600mg/d. And we didn't recommend the dosage of more than 600mg/d.

    Release date:2016-09-07 02:17 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content